ArticleThe Journal of clinical investigation2020

Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity.

Tyler Risom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.